Biotechnology & Medical Research

Medivac Ltd announces appointment of executive Chairman

Medivac Ltd:Says Robert Crossman has been appointed as a director and non executive Chairman, effective immediately.

12:00am EDT

Antisense Therapeutics Ltd completes ATL1103 acromegaly phase II trial dosing

Antisense Therapeutics Ltd:Says that dosing of all 26 patients in the Phase II trial of ATL1103 for the potentially life-threatening growth disorder, acromegaly has now been completed.Says there were no patient withdrawals or reports of any serious adverse events related to dosing with ATL1103.Says...

Monday, 28 Jul 2014 09:00pm EDT

U.S. FDA Grants Regular (Full) Approval for Pharmacyclics Inc's IMBRUVICA for two indications

Pharmacyclics Inc:Says U.S. Food and Drug Administration (FDA) grants IMBRUVICA(ibrutinib) regular (full) approval for treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.Also for treatment of CLL patients with deletion of short arm of...

Monday, 28 Jul 2014 01:18pm EDT

Expansion & New Markets

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.